MYC and B-cell non-Hodgkin lymphoma: Moreover, the HDAC6 inhibitor treatment of DLBCL and B-cell lymphoma cells in Eμ-Myc mice induced MYC degradation, apoptosis, and inhibition of lymphomagenesis [189].